Shares of Proteome Sciences plc (LON:PRM – Get Free Report) shot up 9% during trading on Monday . The company traded as high as GBX 3.91 ($0.05) and last traded at GBX 3.35 ($0.04). 967,070 shares changed hands during mid-day trading, an increase of 496% from the average session volume of 162,146 shares. The stock had previously closed at GBX 3.07 ($0.04).
Proteome Sciences Stock Performance
The company’s 50-day moving average price is GBX 2.73 and its two-hundred day moving average price is GBX 3.15. The stock has a market cap of £9.65 million, a PE ratio of -327.00 and a beta of 0.07.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Further Reading
- Five stocks we like better than Proteome Sciences
- Election Stocks: How Elections Affect the Stock Market
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- What Are Dividend Contenders? Investing in Dividend Contenders
- 2 Drone Stocks Surging from Increased Media Attention
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
